Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Old API Wind-down Ltd - Ordinary Shares ARLZQ

"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently operates in two geographical markets, the United States and Canada. The firm generates most of its reven


OTCPK:ARLZQ - Post by User

Comment by snootchybootchyon Mar 17, 2016 5:24pm
105 Views
Post# 24672322

RE:RE:RE:Come back in 3 years

RE:RE:RE:Come back in 3 years
kuatolives wrote: Well, the company has 50 million in earnings and a good drug pipeline so the company isn't worthless. Bottom has to come sometime.


And let's also remind ourselves that these market conditions are great for companies like Aralez who have lots of cash (from Deerfield) and are looking for acquisitions, even though their share price is also taking a pounding in these conditions.  With cash, there is no need to dilulte shareholders at these low price levels to fund acquistions.
<< Previous
Bullboard Posts
Next >>